全球微针给药系统市场 2023

$1,875.00

产品代码: GP04971I 行业: 地区:
市场概况

The global Microneedle Drug Delivery Systems Market is anticipated to experience significant growth, expanding from USD 2.59 十亿 2022 兑美元 3.82 十亿 2029, at a CAGR of 5.5% 在预测期内 2023-2029. Microneedle drug delivery systems offer a non-invasive and painless approach to administering drugs and vaccines. These systems utilize tiny needles to create micro-pores on the skin, enabling efficient and targeted drug delivery. The market was notably impacted by the COVID-19 pandemic, which prompted the development of innovative skin patches for drug delivery purposes. Companies operating in the market are actively focusing on the advancement of microneedle patches and drug delivery systems.

The increasing prevalence of chronic diseases, such as diabetes and cardiovascular disorders, has created a pressing need for efficient and convenient drug delivery methods. Microneedle systems offer a safer and more patient-friendly alternative to traditional injections, contributing to their rising adoption.

此外, advancements in painless drug delivery research and technological progress have significantly enhanced the efficacy and usability of microneedle drug delivery systems. These advancements have garnered attention from both healthcare professionals and patients, further propelling market growth.

The growing diabetic population and the rise in chronic diseases worldwide have also fueled the demand for microneedle drug delivery systems. These systems provide a convenient and efficient means of administering medications, particularly for individuals who require frequent injections.

而且, ongoing research studies on microneedles and the introduction of new product launches have further stimulated market growth. Market players are actively investing in research and development activities to expand the application areas of microneedle drug delivery systems and improve their performance.

然而, the market does face certain limitations that may impede its growth. The availability of approved products in the market is relatively limited, posing challenges for widespread adoption. 此外, potential complications associated with microneedles, such as skin irritation or infection, need to be carefully addressed to ensure patient safety and confidence.

市场细分

The market is segmented based on product type, 应用, 和地理.

Segmentation by Product Type
Solid
Hollow
Coated
Dissolvable

按应用细分
Drug Delivery
Vaccine Delivery
Dermatology
其他的

按地理位置细分
北美 – 美国, 加拿大, and Mexico
欧洲 – 英国, 德国, 法国, 意大利, 西班牙, 和欧洲其他地区
亚太 – 中国, 日本, 韩国, 印度, 澳大利亚, 以及亚太地区其他地区
世界其他地区

The microneedle drug delivery market is expected to grow in vaccine delivery due to the increasing prevalence of influenza and viral infections. Microneedle vaccinations have shown effectiveness in generating a strong immune response by delivering vaccines efficiently to immune cell-rich skin regions. The use of sustained-release polymers or integrated microparticles and nanoparticles in microneedles can eliminate the need for multiple vaccinations, increasing demand for such vaccine delivery systems. 此外, company focus on business strategies like mergers and collaborations, along with more vaccine launches, will contribute to the growth of the vaccine delivery segment.

The North American market for microneedle drug delivery systems is expected to grow due to the rising prevalence of chronic, skin, and infectious diseases. Technological advancements in microneedle fabrication further promote adoption. The region’s burden of chronic diseases and high flu cases drive demand for microneedle drug delivery. Strategic initiatives like collaborations contribute to market growth. In conclusion, the microneedle drug delivery market, especially for vaccines, will see significant growth due to infectious diseases, technological advancements, and strategic initiatives.

竞争格局

The market for microneedle drug delivery systems is fragmented and highly competitive, with a few major players holding dominant market share. Key companies in this market include Becton, 迪金森公司, 坎德拉公司, Corium Inc., CosMED Pharmaceutical Co., 有限公司, Debiotech S.A., LTS Lohmann Therapie-Systeme AG, Micropoint Technologies Pte Ltd, nanoBioSciences, 有限责任公司 (DBA AdminMed), NanoPass Technologies Ltd., Raphas Co., 有限公司, 除其他外.

最新行业发展

In October 2022, Emergex Vaccines Holding Limited successfully acquired Zosano Pharma Corporation’s assets. These assets include valuable intellectual property, license agreements, manufacturing equipment, and Zosano’s proprietary microneedle array patch (MAP) intradermal drug delivery system. The acquisition also included rights to solid-coated microneedle array patch technology, formulation and coating methods, and specialized equipment.

CGBio, a South Korean healthcare provider, launched CGDew Derma Regen, a new skin care patch in November 2022. The patch is part of their microneedle pipeline and is made from various materials such as silicon, 钛, 不锈钢, and polymers. It aims to improve medication diffusion by creating tiny pores on the skin.

为什么选择这份报告

Gain a reliable outlook of the global microneedle drug delivery systems market forecasts from 2023 到 2029 跨场景.
确定投资的增长领域.
通过公司简介和市场数据领先于竞争对手.
Excel 格式的跨场景分析易用性的市场预估.
三个月的战略咨询和研究支持.
为单用户许可证提供打印验证.

全球微针给药系统市场 2023

对这份报告感兴趣? 立即获取免费样品!
全球微针给药系统市场 2023 - 报告范围
报告属性

细节

市场规模 (2022)

美元 2.59 十亿

基准年

2022

预测年份

2023-2029

复合年增长率 (2023-2029)

5.5%

页数

21

细分依据

产品类别, 应用, 地理

覆盖地区

全球的

行业参与者

贝克顿迪金森公司, 坎德拉公司, Corium Inc., CosMED Pharmaceutical Co. 有限公司, Debiotech S.A., LTS Lohmann Therapie-Systeme AG, Micropoint Technologies Pte Ltd, nanoBioSciences LLC (DBA AdminMed), NanoPass Technologies Ltd., Raphas Co. 有限公司.

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - 全球微针给药系统市场 2023

请填写我们的表格,我们会尽快回复您.